Hello. I had a very specific question regarding journal reprints. With respect to clinical reprints that are more focused on disease state and/or are meant to be practice defining documents (clinical resource documents, guidelines); can they be shared in a promotional way by sales reps (ie with accompanying word of mouth, in proactive manner etc).
I understand that in a previous question, it was clarified that clinical reprints must abide by PAAB codes sections 2,3,4,5. However, in section 3.1.1 it states that Review articles, pooled data,
meta-analysis, post-hoc analysis, and observational studies are
generally regarded as not being evidence to support claims in drug
advertising. However, in the context of review articles discussing disease state or practice defining documents, does this point still apply? as the reprint is meant to raise awareness on the disease state and clinical practice for managing the patient population?
thanks in advance for your consideration and support.